Cas 628722-39-4,2-O-benzyl-1,3-bis-(1,2-O-dimyristoyl-sn-glycero-3-phosphoryl)glycerol dimethyl ether

628722-39-4

Post Buying Request

Basic information

Product Name: 2-O-benzyl-1,3-bis-(1,2-O-dimyristoyl-sn-glycero-3-phosphoryl)glycerol dimethyl ether
Synonyms: 2-O-benzyl-1,3-bis-(1,2-O-dimyristoyl-sn-glycero-3-phosphoryl)glycerol dimethyl ether
CAS NO:628722-39-4
Molecular Formula:
Molecular Weight: 1359.83
EINECS: N/A
Product Categories: N/A
Mol File: 628722-39-4.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-O-benzyl-1,3-bis-(1,2-O-dimyristoyl-sn-glycero-3-phosphoryl)glycerol dimethyl ether(CAS DataBase Reference)
NIST Chemistry Reference: 2-O-benzyl-1,3-bis-(1,2-O-dimyristoyl-sn-glycero-3-phosphoryl)glycerol dimethyl ether(628722-39-4)
EPA Substance Registry System: 2-O-benzyl-1,3-bis-(1,2-O-dimyristoyl-sn-glycero-3-phosphoryl)glycerol dimethyl ether(628722-39-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 628722-39-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

628722-39-4 Suppliers

Recommended suppliersmore

628722-39-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 628722-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,8,7,2 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 628722-39:
(8*6)+(7*2)+(6*8)+(5*7)+(4*2)+(3*2)+(2*3)+(1*9)=174
174 % 10 = 4
So 628722-39-4 is a valid CAS Registry Number.

628722-39-4Upstream product

628722-39-4Downstream Products

628722-39-4Relevant articles and documents

NUCLEOSIDE-LIPID CONJUGATES, THEIR METHOD OF PREPARATION AND USES THEREOF

-

Example 8, (2008/06/13)

The invention provides methods for synthesizing nucleoside-lipid conjugates having varying fatty acid and alkyl chain lengths with or without unsaturation and their use in the treatment of cancer and viral diseases. More particularly, the invention provid

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 628722-39-4